Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
177.20
+0.74 (+0.42%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Wall Street Sets New Records As Magnificent Seven Valuation Tops $18.5 Trillion: This Week In Markets
July 18, 2025
Wall Street rose to new heights during the week amid strong earnings and solid economic data. Meanwhile, Fed rate cut debate heats up.
Via
Benzinga
Topics
Economy
Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie
July 18, 2025
This week's M&A news includes strategic pivots and stumbles galore, with updates from WK Kellogg, Matador Restaurant and Windsurf.
Via
Benzinga
Stock Of The Day: Breakout In Johnson & Johnson
July 17, 2025
Shares of Johnson & Johnson broke out of a classic ascending triangle pattern. They have since stalled out at resistance.
Via
Benzinga
Want Steady Income? 3 Top Dividend Stocks for July 2025
July 17, 2025
Three dividend stocks stand out in July, offering reliable income, attractive yields, and strong fundamentals to help investors navigate market volatility
Via
MarketBeat
Topics
Economy
Lawsuit
World Trade
Johnson & Johnson Reportedly Halves Its Forecast Of US Tariff Impact To $200M, Sparks Retail Chatter
July 16, 2025
Via
Stocktwits
Johnson & Johnson Ups Forecast, Beats On EPS—But Wall Street Is Cautious
July 17, 2025
Johnson & Johnson earnings came in 3% higher than consensus. The company's operating leverage was "slightly diluted by higher tax."
Via
Benzinga
Johnson & Johnson Analysts Raise Their Forecasts After Upbeat Earnings
July 17, 2025
Via
Benzinga
Johnson & Johnson, Intercontinental Exchange And Bitcoin ETF On CNBC's 'Final Trades'
July 17, 2025
Investors monitor shifting market dynamics and consumer behavior post-pandemic, with Sarat Sethi sticking with Johnson & Johnson amid a positive earnings report. Stephen Weiss picks iShares Bitcoin...
Via
Benzinga
Topics
ETFs
Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
July 17, 2025
Via
The Motley Fool
Topics
Bonds
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
July 17, 2025
Via
The Motley Fool
Johnson & Johnson Credits Tariff Delays For Strong Earnings, While Jim Cramer Pegs It On 'Lower Than Thought' Levies
July 17, 2025
Johnson & Johnson hinted at leveraging tariff delays to maintain its outlook; however, Jim Cramer credited the performance to lower tariffs.
Via
Benzinga
Topics
World Trade
Market Monitor News July 17 BMO (Johnson & Johnson, Brighthouse Financial UP - GrabAGun DOWN)
July 17, 2025
Powell Panic, Pharma Power & a PEW Parade: Wall Street’s Wild Wednesday
Via
Chartmill
Wall Street Cheers J&J’s Outlook: Morgan Stanley, Stifel Raise Targets After Q2 Beat and Guidance Lift
July 16, 2025
Analysts highlighted momentum in oncology and MedTech, with Wells Fargo calling the second-half growth acceleration “achievable” and Morgan Stanley noting visibility risks from drug pricing and tariff...
Via
Stocktwits
Topics
Government
World Trade
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
July 16, 2025
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78.
Via
Benzinga
Topics
Stocks
3 Top Dividend Stocks Yielding More Than 3% That You Shouldn't Hesitate to Buy Right Now
July 16, 2025
Via
The Motley Fool
JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
July 16, 2025
Johnson & Johnson is back in rally mode after years of post-pandemic normalization and the impact of repositioning, set up to sustain higher prices for years.
Via
MarketBeat
Johnson & Johnson Lifts 2025 Outlook
July 16, 2025
Via
The Motley Fool
Topics
Intellectual Property
Why Johnson & Johnson Rallied Today
July 16, 2025
Via
The Motley Fool
Topics
World Trade
Johnson & Johnson Tops Q2 Estimates
July 16, 2025
Via
The Motley Fool
Topics
Intellectual Property
Gold, Bitcoin Surge As Trump Eyes Powell Ouster: What's Moving Markets Wednesday?
July 16, 2025
Volatility surged across interest rate-sensitive assets Wednesday after reports circulated that President Donald Trump may be preparing to remove Federal Reserve Chair Jerome Powell from his post. The...
Via
Benzinga
Topics
Economy
Government
10 Health Care Stocks Whale Activity In Today's Session
July 16, 2025
Via
Benzinga
Johnson & Johnson Raises FY25 Forecast, Joins Rigetti Computing, Unity Software, Brighthouse Financial And Other Big Stocks Moving Higher On Wednesday
July 16, 2025
Via
Benzinga
What's going on in today's session: S&P500 movers
July 16, 2025
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via
Chartmill
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript
July 16, 2025
Via
The Motley Fool
Topics
Earnings
Dow Health Giant J&J Surges After Hiking Outlook On Strong Quarterly Report
July 16, 2025
The company also easily beat second-quarter adjusted earnings and sales forecasts.
Via
Investor's Business Daily
Topics
Stocks
Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance
July 16, 2025
Johnson & Johnson beat Q2 estimates and raised its 2025 outlook, driven by strong cancer and MedTech sales despite Stelara declines.
Via
Benzinga
Johnson & Johnson (NYSE:JNJ) Reports Bullish Q2, Full-Year Sales Guidance is Optimistic
July 16, 2025
Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 5.8% year on year to $23.74 billion. The company’s full-year revenue...
Via
StockStory
Johnson & Johnson Outperforms Q2 Expectations; Provides Positive Outlook
July 16, 2025
Johnson & Johnson surpassed expectations in Q2 2025 with a notable increase in earnings per share and revenue.
Via
Talk Markets
Dow Futures Edge Up Even As Investors Maintain Caution: ASML, UAL, JNJ, BAC, GS Among Stocks To Watch
July 16, 2025
Via
Stocktwits
Topics
Stocks
3 Magnificent S&P 500 Dividend Stocks Down 16% to 20% to Buy and Hold Forever
July 16, 2025
Via
The Motley Fool
Topics
Stocks
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.